Litigator of the Week: Stephen Neal of Cooley

, The Litigation Daily

   | 0 Comments

When Roche tried to stake a claim to Gilead Sciences' blockbuster Hepatitis C drug, Gilead turned to Cooley to neutralize the threat.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202667685109

Thank you!

This article's comments will be reviewed.